117 results
8-K
EX-99.2
AXDX
Accelerate Diagnostics Inc
29 Mar 24
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
5:19pm
period. This was partially offset by an increase in recurring consumable net sales.
Gross margin was approximately 21% for the quarter and year-to-date
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
in the development and commercialization of our Accelerate Wave system. There is no assurance that we will achieve sufficient revenues to offset anticipated … to offset our fixed expenses, our liquidity will continue to be adversely affected.
If we fail to estimate customer demand properly, our financial results
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
revenues to offset anticipated operating costs, and we expect to continue to incur losses in the future. Our ability to achieve or sustain profitability … and test cartridges to offset our fixed expenses, our liquidity will continue to be adversely affected.
If we fail to estimate customer demand properly
S-1
105o bc8tr
13 Dec 23
IPO registration
5:30pm
8-K
EX-4.1
beqffl
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-99.2
y2041dbqwrvia qgk9j0
15 Nov 22
Accelerate Diagnostics Reports Third Quarter 2022 Financial Results
4:49pm
424B5
4wfv0i1fbt6finz e2
22 Aug 22
Prospectus supplement for primary offering
4:11pm
424B5
0sm61uq6qdh0aalx4
17 Aug 22
Prospectus supplement for primary offering
6:13pm
8-K
EX-99.1
mlmn01
15 Aug 22
Accelerate Diagnostics Reports Second Quarter 2022 Financial Results
8:26am
8-K
EX-99.1
iira a7g3
8 Mar 22
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2021 Financial Results
4:11pm